Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer-Reference-Cited by-同舟云学术

Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer

Published:2021-02 Issue: Volume:152 Page:149-156
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ronden Merle I.^ORCID,Bahce Idris^ORCID,Hashemi Sayed M.S.^ORCID,Dickhoff Chris,de Haan Patricia F.,Becker Annemarie,Spoelstra Femke O.B.,Dahele Max R.^ORCID,Ali Rania^ORCID,Tiemessen Marian A.^ORCID,Tarasevych Svitlana,Maassen van den Brink Karen,Haasbeek Cornelis J.A.,Daniels Johannes M.A.^ORCID,van Laren Marjolein,Verbakel Wilko F.A.R.,Senan Suresh^ORCID

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference47 articles.

1. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS;Park;Ann. Oncol.,2020

2. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J. Clin. Oncol.,2010

3. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020.

4. An appraisal of clinically meaningful outcomes guidelines for oncology clinical trials;Kumar;JAMA Oncol.,2016

5. Population-based patterns of surgical care for stage IIIA NSCLC in the Netherlands between 2010 and 2013;Dickhoff;J. Thorac. Oncol.,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cloud platform to improve efficiency and coverage of asynchronous multidisciplinary team meetings for patients with digestive tract cancer;Frontiers in Oncology;2024-01-15

2. Challenges to multimodal treatment of elderly patients with lung cancer;Die Onkologie;2024-01-02

3. Identification of age‐ and immune‐related gene signatures for clinical outcome prediction in lung adenocarcinoma;Cancer Medicine;2023-07-11

4. Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice;Journal of Cancer Research and Clinical Oncology;2023-07-05

5. The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation;Clinical Lung Cancer;2023-03